Biogena Group Invest AG
Biogena Group Invest AG engages in the provision of dietary supplements. The company is based in Salzburg, Austria.
Market Cap & Net Worth: Biogena Group Invest AG (BIO)
Biogena Group Invest AG (VI:BIO) has a market capitalization of $12.53 Million (€12.21 Million) as of March 18, 2026. Listed on the VI stock exchange, this Austria-based company holds position #43079 globally and #42 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Biogena Group Invest AG's stock price €3.06 by its total outstanding shares 3990000 (3.99 Million).
Biogena Group Invest AG Market Cap History: 2026 to 2026
Biogena Group Invest AG's market capitalization history from 2026 to 2026. Data shows growth from $12.53 Million to $12.53 Million (0.00% CAGR).
Biogena Group Invest AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Biogena Group Invest AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of BIO by Market Capitalization
Companies near Biogena Group Invest AG in the global market cap rankings as of March 18, 2026.
Key companies related to Biogena Group Invest AG by market ranking:
- Nestle SA (PINK:NSRGF): Ranked #56 globally with a market cap of $258.19 Billion USD.
- Nestlé S.A. (SW:NESN): Ranked #69 globally with a market cap of $226.26 Billion USD ( CHF207.18 Billion CHF).
- Danone S.A (OTCQX:GPDNF): Ranked #436 globally with a market cap of $49.73 Billion USD.
- Danone SA (PA:BN): Ranked #456 globally with a market cap of $47.28 Billion USD ( €46.06 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #56 | Nestle SA | PINK:NSRGF | $258.19 Billion | $100.43 |
| #69 | Nestlé S.A. | SW:NESN | $226.26 Billion | CHF80.61 |
| #436 | Danone S.A | OTCQX:GPDNF | $49.73 Billion | $78.67 |
| #456 | Danone SA | PA:BN | $47.28 Billion | €72.84 |
Biogena Group Invest AG Historical Marketcap From 2026 to 2026
Between 2026 and today, Biogena Group Invest AG's market cap moved from $12.53 Million to $ 12.53 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €12.53 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Biogena Group Invest AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.53 Million USD |
| MoneyControl | $12.53 Million USD |
| MarketWatch | $12.53 Million USD |
| marketcap.company | $12.53 Million USD |
| Reuters | $12.53 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.